ET
RCKT icon

Entropy Technologies’s Rocket Pharmaceuticals RCKT Stock Holding History

Entropy Technologies’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-24,612
Closed -$164K – 982
2025
Q1 		$164K Buy
+24,612
New +$243K 0.02% 646
2024
Q2 		– Sell
-13,544
Closed -$365K – 893
2024
Q1 		$365K Sell
13,544
-3,800
-22% -$108K 0.04% 520
2023
Q4 		$520K Buy
+17,344
New +$383K 0.1% 334

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Entropy Technologies's RCKT Position: Q2 2025 in Review

Entropy Technologies sold out of Rocket Pharmaceuticals (RCKT) in Q2 2025, closing a stake of 24,612 shares — an estimated $164K sold.

Entropy Technologies first reported a position in RCKT in Q4 2023 and held it in 3 quarters. The position peaked at $520K in Q4 2023. 196 funds tracked by Wall St. Rank hold RCKT as of Q2 2025.

  • Entropy Technologies reported no remaining Rocket Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Entropy Technologies sold 24,612 Rocket Pharmaceuticals shares in Q2 2025, an estimated $164K.
  • Entropy Technologies first reported a position in Rocket Pharmaceuticals in Q4 2023 and held it in 3 quarters.
  • Entropy Technologies's Rocket Pharmaceuticals position peaked at $520K in Q4 2023.
  • 196 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2025.

Based on Entropy Technologies's 13F filing for Q2 2025, filed 12 Aug 2025.